We are live on
!
Find out more
UMC
UNC Management Company Portfolio holdings
AUM
$2.07B
1-Year Est. Return
21.32%
This Fund
S&P 500
This Quarter
Est. Return
-5.18%
1 Year Est. Return
+21.32%
3 Year Est. Return
+92.02%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$179M
AUM Growth
-$10.2M
(-5.4%)
Cap. Flow
+$1.52M
Cap. Flow
% of AUM
0.85%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pliant Therapeutics
PLRX
|
+$961K |
| 2 |
Samsara
IOT
|
+$527K |
| 3 |
Riley Exploration Permian
REPX
|
+$33.6K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0.59% |
| 2 | Technology | 0.25% |
| 3 | Energy | 0.01% |
Similar funds
DE
DF
OAM
WFMPM
ST
OPAM
CAM
NCMU
UNC Management Company's Q3 2022 Portfolio in Review
As of Q3 2022, UNC Management Company held 4 positions worth $179M, down 5.4% from $189M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
UNC Management Company's Q3 2022 filing shows 3 new positions. Its largest new stake was Pliant Therapeutics: 50,201 shares worth $1.05M.
By sector, the portfolio is most concentrated in Healthcare at 0.59% of assets, up from 0% a quarter earlier, followed by Technology and Energy.
- UNC Management Company's largest Q3 2022 buy was Pliant Therapeutics: 50,201 shares worth $1.05M.
- UNC Management Company's ten largest holdings make up 100% of its $179M portfolio in Q3 2022.
- UNC Management Company opened 3 new positions and closed 0 in Q3 2022.
- UNC Management Company's portfolio value fell 5.4% quarter-over-quarter to $179M.
Based on UNC Management Company's 13F filing for Q3 2022, filed 14 Nov 2022.